Abattis Bioceuticals Corp. (ATTBF)

[Shaark]

'guay' It's not a matter of chopping & changing, but predicated on the numbers you provided, it appears that the management of ATTBF, pays itself first, foremost & with both hands in the till, I see too much greed, never a good thing. GLTA Play it as you see it

[guay]

Cannabis R&D Firms See Wild Growth Curve
http://www.prnewswire.com/news-releases/cannabis-rd-firms-see-wild-growth-curve-643941353.html
ATT has diversified its operations into several segments, from research and certification in its testing and lab facilities, to formulations and extracts exclusive to Northern Vine Labs and to products provided by its Vergence subsidiary.
Although relatively new as a fully operational cannabis sector company, ATT has managed to bring together valuable assets and tripled its price since one year ago. With the early interest and pent up demand for services, Abattis Bioceuticals looks like a real potential leader as this sector continues its major momentum drive.

[guay]

Hi Shaark – you said ATTBF will probably re-adjust downward – sure, a little bit. I will hold my position. Chopping and changing is not my case. Hope to see you back - GLTY

[Shaark]

'guay' The picture that is painted with these numbers, is rather bleak & does not bode well going forward. ATTBF will probably re-adjust downward, I sold my position & will take a wait & see attitude @ this time. GLTA Play it as you see it

[guay]

Why Pot Stocks Stumbled
five key causes for the recent largely-unexpected slump in Canada’s cannabis stocks.
Fortunately, these sobering sell-off signals are counter-balanced by five compelling reasons for cannabis stocks to bounce back with a vengeance.
http://www.cannabiscapitalist.ca/single-post/2017/08/09/Why-Pot-Stocks-Stumbled

Problem #5: Short Sellers Smell Blood
Short selling day traders are taking advantage of industry-wide profit-taking by adding more selling pressure. This absence of any macro drivers to power the industry higher for the foreseeable future emboldens them and minimizes their trading risks.
Also, the all-too-common and highly controversial practice of naked short selling –– especially by stock market professionals –– offers unfair trading advantages to the shorters. Typically, it’s ordinary retail investors who get fleeced this way.

Solution #5: A Trend Reversal Should Spook Short Sellers
Starting this autumn, government lawmakers are due to provide legal cannabis growers with a clearer road map to the looming multi-billion dollar recreational market for cannabis –– which commences next summer.
Once this legislation takes shape, cannabis stocks are destined to do an about-face by reversing their trading trends. Virtually all cannabis stocks should be beneficiaries of this renewed impetus, including the good, the bad, and the ugly. So caveat emptor!
Ultimately, the better stocks will thrive while the shams, scams and other ill-conceived stock plays will fade away.
The upshot of all of this is that most short sellers will cover their positions and start to look for easy prey elsewhere in other industries. They will not want to put up much of a fight against an aggressively ascendant industry trend.

[guay]

Yes please illume this board with your insight and your knowledge - and if possible please something we can't read in any quarterly reports

[guay]

Yes ... unfortunately I can not keep up with your very valuable contributions – and sorry for You that You screwed up ...

[StarFishPatrick]

Tip: be realistic and provide neutral not puff advice - insight or knowledge goes a very long way.

[StarFishPatrick]

Not sure why you posted this to me - it proves my point.

[farviewhill]

BARCHART 86% Strong Buy!
.30 here we come.

[StormanNorman]

Some can't see forward. I'm waiting for Guay to post something from 2015 - 2016. Sorry, but you add no value to this board.

ATTBF isn't moving like it did the last run. .25 isn't looking good. I screwed up cuz I knew .10 was an easy buy price to make money.

Attbf

[guay]

Agree ... and the next wave up - above 0.30 - I expect for the beginning of next year.

[GreenBrickRoad]

Abattis is at the mercy of a drastic political shift, which is always going to drag on slower than people invested in these companies would hope for. The name of the game for ATTBF has been to stay alive, don't scare everyone off with too much dilution (though there will, inevitably, be some), and build opportunities along the way. That gives them a chance to turn a profit in next 1-2 years. That chance aside, just staying alive will allow them to ride the next wave up.. Not sure if it's coming by the end of this Fall or in 2018, but it's coming. I feel like anyone selling now is throwing away a 90%+ chance of a 50-100% ROI in 1 year or less.

[GreenBrickRoad]

It's going back to the 0.20's. The question is how quickly. Summer is always a drag on MJ stocks, and ATTBF has never been an exception. Abenante believes in delivering news.. even if it's often rehashed news.. which drives excitement.

[guay]

... indeed, it takes them a while to make money – but in the histories of new arising economic sectors you find always those "others little" businesses who have sold the basic needs, the requirements, the tools, all these widgets for the implementation. That were the ones who became at the end important companies of these new sectors. I am convinced that Abattis has an important and soon profitable position in the emerging cannabis industry.

[guay]

Tip: Invest in a company to which you have more confidence. It is a free country – sell your shares and invest or speculate in a stock company that paid less for "those efforts".

[guay]

Nine months ended June 30, 2017 compared with nine months ended June 30, 2016
The Company incurred a net loss of $3,953,413 during the period ended June 30, 2017 an increase of $2,372,871 when compared with the loss of $1,580,542 for the period ended June 30, 2016. The increase in net loss is primarily the result of the change in the followings expenses during the period ended June 30,2017:

• Accounting and audit fees increased from $20,000 to $88,904 for the period ended June 30, 2017. This increase is

primarily due to a focus on cost containment and efficiency as well as establishing the in-house accounting.

• Advertising expenses decreased to $38,061 for the period ended June 30, 2017, from $69,094 for the period ended June 30,2016.Thisdecreaseisprimarilyduetoafocusoncost containment andefficiency.

• Legal fees increased to $93,362 for the period ended June 30, 2017, from $49,549 for the period ended June 30, 2016. This increase is primarily due to higher legal fees incurred in respect of the acquisitions, issuance of stock options and share issuances during the period ended June 30, 2017.

• Management and consulting fees increased to $2,795,925 for the period ended June 30, 2017 from $893,407 for the period ended June 30, 2016. The increase was primarily a result of different fees charged to consultants for new business ventures as well as payments made on management changes.

• Office and general administration fees decreased to $375,809 for the period ended June 30,2017,from $341,453 for the period ended June 30, 2016. This decrease is primarily due to lesser corporate activity in the Company’s subsidiaries duringtheperiod.

•Regulatoryandtransferagentfeesincreasedto$47,811fortheperiodendedJune30,2017,from$39,375fortheperiod ended June 30, 2016. This increase is primarily due to expenses related to the Annual General Meeting and postponement thereof.

• Research costs decreased to $20,658 for the period ended June 30, 2017, from $34,647 for the period ended June 30, 2016. This decrease is primarily attributed to the Company’s focus on due diligence relating to the acquisition of the technology distribution agreement for extraction machines.

• Share based payment increased to $540,017 for the period ended June 30,2017,from $4,886 fort heperiod ended June 30, 2016. This increase is due to an increase in personnel and the wish to conserve cash for business development purposes during the period ended June 30,2017.

(Page 6 of 20)

Key management personnel compensation During the periods ended June 30, 2017 and 2016, compensation to key management personnel and related parties were as follows:
June 30, 2017 June 30, 2016 Remuneration, fees and short-term benefits 0$
Management and consulting fees (1) 1,769,685 (2017)
277,951 (2016)
(1)Includes directors’ bonus paid by issuance of 5,500,000 shares with an aggregate fair value of $934,063.

Source: www.sedar.com / abattis - Management Discussion and Analysis For the nine months ended June 30, 2017

(Page 8 of 20)

[StarFishPatrick]

1 million shares? Almost 200,000 CAD for these efforts?

[StarFishPatrick]

I simply can't understand why you wouldn't want them to operate the company in an appropriate manner. Again, I've shown that I have knowledge of actual company actions and situations. What have you ever provided to the discussion that was substantive and could actually provide someone with helpful and useful info?

[ebota12]

Yeah, I choose not to show huge losses to my father in law, who is a CPA and does my taxes every year.

[dangerx]

Choices speak louder than words and you still choose to be here. Let's see where the wind takes it...

[guay]

worth reading – Cannabis Lab Testing Is The Industry's Dirty Little Secret
https://www.forbes.com/sites/debraborchardt/2017/04/05/cannabis-lab-testing-is-the-industrys-dirty-little-secret/#6f9837401220

worth watching - Cannabis Lab Tour - Behind the Scenes at Oregon's MRX Labs

[guay]

Abattis Prepares for Growth in Extracts
Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) represents a unique investment opportunity in the cannabis extracts space. With their distribution agreement in place with Raybot, the company has access to cutting-edge technology that enables the scalable production of highly purified cannabinoids at an extremely low cost. These benefits dovetail nicely with the company’s other downstream products and services, discussed in an earlier article.

Investors may want to take a closer look at the stock as the company gears up to scale its cannabis extracts business and create tremendous value in the cannabis industry. The company’s Northern Vine subsidiary plans to provide extraction, testing, analysis, formulation and other services to licensed producers in Canada to develop co-branded and white-label products.
http://www.cannabisfn.com/abattis-prepares-growth-extracts/

[ebota12]

Because unfortunately I've been here a long time. The company blows.

If I get time I'll update my MOD sticky with some comedy.

[Mr Hand]

@ebota12 why so much hate?

[ebota12]

This is precisely the bullshit that frustrates long time investors. No new information here. No progress. Just "plans". Probably gave away 10's of thousands of shares for this fluff piece.

[Mr Hand]

Just got this

http://www.cannabisfn.com/abattis-prepares-growth-extracts/

[GreenBrickRoad]

Is Abattis at 200 Mil O/S yet?

[GreenBrickRoad]

I don't enjoy seeing dilution and shares being passed out, but it's kind of like buying a car and then complaining about gas, insurance, and ongoing maintenance expenses. These are things necessary for the car to remain functional, and so it's true with incentive for management to keep this company going in the right direction.

Yes, there were times last year when I felt certain "directors" were compensated too generously. Remember the late filings? I have no problem with that complaint from investors. But now that the company is actually rolling forward, you have to expect them to reach out and grab something for their effort.

[guay]

always the same old story and always harping on the same theme ... hoping that finally one of your self-fulfilling prophecies come true?

[StarFishPatrick]

Take a look at the goodies they are handing out to insiders and those insiders selling in Canada.

https://m.canadianinsider.com/company?menu_tickersearch=ATT%20%7C%20Abattis%20Bioceuticals

[farviewhill]

Abattis is in the most reliable and best money generating segment of the cannabis industry.
To make Abattis even a better investment than it's US counterpart EVIO, also a smart investment, is the fact that Abattis is Canadian based and has a nationwide politically accomodating rapidly growing presence.

[ebota12]

Welcome to Dumpsville. Population: US

[farviewhill]

I share your very bullish assessment.

ABATTIS is a gem of an investment with huge upside potential based on sound fundamentals and canadian nation-wide acceptance of the cannabis industry.
Canadian cannabis stocks, including a most crucial and unique cannabis TESTING one like Abattis, will far out performing their US counterparts.

[Penny Masters]

Many will find ATTBF soon enough. July 2018 will have many of these up 100-500% in a blink as many will want in at these levels.

[farviewhill]

We and others need to do all we can to increase the investor base by doing all we can to get the word out on other boards, etc., on the gem we have here.

[guay]

entirely agree !

[farviewhill]

License producers need to go through mandated testing and this is where a major company like Abattis shines. IMO, testing is one of the surest and safest investing components of the cannabis industry.
Revenues will dramatically grow and so will the share price reflecfting this.
I strongly consider Abattis an up and coming cannabis portfolio stock tyo buy and accumulate. GLTY

[ebota12]

Either that, or a good time for the promoter who received 250,000 shares to dump them.

[farviewhill]

I agree. Good decision by management.

Today's modest share price weakness, following so much much strength, is a good time to start or do some adding to one's position in Abattis.
Abattis is definitely, imo, a stock to be accumulating in one's cannabis portfolio, as it is clearly going to continue it's upward share price march in the days to come.
t's a portfolio stock of the emerging quality kind, and belongs with the major quality ones like General Canopy, Aphria, and Aurora.

Great day to accumulate Abattis. Seize the opportunity.

[Mr Hand]

@ebota12 #30297 19% of a grow that still has to go through a number of hoops to be in operation - couple of test crops and then Health Canada weighs in on whether or not the LP is allowed to grow and sell to LDs. Or, 100% of an LD that is already in operation? Management made the right call on this one.

[guay]

I do not know how often you have to say something. However ... what I can tell you is that people who insist on being right are a little bit suspect. The truth is usually neither black nor white...

[StarFishPatrick]

How many times do I have to be right before you start to acknowledge that I may actually know a little bit about what I am talking about?

[StarFishPatrick]

Bad blood between principals.

[guay]

Nonsense... "Some marriages work better with separate beds". Everybody knows that LP's can not control or test themselves. This "separation" means - Experion will become a good 'Northern Vine' costumer and a trustworthy partner for experiments that require a cultivation expert.

[ebota12]

I could see why Experion would hate Abattis, but I'm curious why Abattis would hate Experion.

[StarFishPatrick]

I guess we now know that amazing MOU (whereby Abattis could purchase 100% of Experion) that was touted was actually not in effect. I don't mean to gloat - but people really should listen to what I have to say.

These two companies (Abattis & Experion) hate each other. This was a deal to divorce and get the hell away from each other.

[Penny Masters]

ATTBF - Lets see 10-20 million traded daily.

[ebota12]

19% of an LP for 25% of a tester? I guess that's the question.

[guay]

Abattis Bioceuticals Corporation and Morro Bay Resources Ltd. Announce Agreement for a Share Swap Between Experion Biotechnologies Inc. and Northern Vine Canada Inc.
The Swap Agreement will result in Northern Vine no longer owning any shares in Experion and Experion no longer owning any shares in Northern Vine. The Swap Agreement and all closing documents related thereto have been executed with final closing anticipated to occur after the previously announced Morro Bay and Experion reverse take-over transaction (the “RTO”) has been completed and within two days after the Morro Bay’s common shares have traded for five (5) days. If closing of the Swap Agreement does not occur by October 13, 2017 the Swap Agreement is null and void.
https://www.fscwire.com/newsrelease/abattis-bioceuticals-corporation-and-morro-bay-resources-ltd-announce-agreement-share